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Purpose/Objective: The dose calibration of the tomotherapy system 
consists on the comparison of the dose calculated by the treatment 
planning system (TPS) with that measured on a cylindrical Virtual 
Water phantom for a clinical plan. This method depends on the 
accuracy of the density curve of the CT as well as on the consistency 
of the phantom within time. In this work we have developed a static 
tomotherapy (TomoDirect) plan delivered on a water phantom which 
allows us to apply the TG-148 protocol on absolute dose measurement 
of static fields in tomotherapy and compare it with the dose rate 
output of the machine modelled in the TPS. 
Materials and Methods: The plan consisted on the contouring of a 
rectangular region of interest (ROI) of dimensions 15x40x20 cm3 to 
which a density of 1g/cm3 was assigned. This ROI is placed centered at 
the isocenter of the machine. Inside, another ROI was contoured at 
the isocenter in order to use it as a target during the planning 
process. The dimensions of this ROI were 10 cm long at the transversal 
direction and 1 pixel in all the other directions. A TomoDirect plan 
was created with two opposite beams at 0º and 180º gantry angles 
with a jaw width of 5cm. Full dose and final dose calculations were 
performed after the first iteration of the optimization process, 
leading to a plan with two identical and very low modulated beams 
witha field size of 5x10cm2. Hence, TG-148 can be applied and kqq0 can 
be obtained from the method suggested by Thomas et al (Med Phys 
2005 May; 32(5):1346-53). The beam at 0º was measured in a 
rectangular Virtual Water phantom whose geometry equals that of the 
ROI in the plan. Previously, equivalency between the phantom and 
water at that point was checked. The results obtained were then 
compared with the reference dose established during the acceptance 
of the system and with the expected dose rate calculated based on 
the energy fluence per ideal open time(EFIOT) included in the TPS. 
Results: Difference between dose calculated by the TPS and that 
measured was within a 0.1% once the dose was corrected by our 
reference dose rate, which was set during the acceptance of the 
system. These results suggest that the reference dose rate of our 
system with a 5x40cm2field at a1.5cm depth and SSD 85cm should be 
837 cGy/min. Given that the EFIOT stored in our TPS has a value of 
3.4767x1010 MeV/cm2, the theoretical dose rate should be 855.6 
cGy/min. Therefore, a discrepancy of a 1% was found. Results of this 
work show that a factor can be established between the dose rate 
stored at the TPS (EIOF) and that measured in a static reference field. 
This factor has a value of 4.0124x10-10cGy.cm2/MeV. 
Conclusions: A direct relationship was obtained between the dose 
rate data stored in the TPS and that measured in a static beam in 
reference conditions. The factor obtained between these two 
parameters could be useful in the calibration of any Tomotherapy 
unit. 
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Purpose/Objective: DosimetryCheck (DC) (Math Resolutions) is a 
commercial EPID based dosimetry software, which allows performing 
pre-treatment and transit dosimetry. DC provides invivo 3D dose 
which can be displayed on the CT of the patient and provides an 
independent verification of the treatment, being potentially of great 
interest due to the high benefits of the in vivo volumetric dosimetry, 
which guarantee the treatment delivery and anatomy constancy. The 
aim of this work is to study the differences of reference point doses 
between DC and TPS to establish an accuracy level of the system. 
Materials and Methods: We used DC v.3.8 with the EPIDs of two 
Varian iX. TPS was Eclipse v.10.0 with AAA algorithm. DC employs 
pencil beam algorithm. DC settings require a series of EPID integrated 
images acquired with increasing thicknesses of water interposed in the 
beam. Two specifically designed methacrylate tanks were built for 
that purpose. To test theresults of DC two phantoms were used: MP1 
Water Tank and Solid Octavius 4D cylindrical phantom (PTW). Several 
plans were generated: (1) Four-field plan with MP1 base in contact 
with the couch (no air gap); (2) Four-field plan with MP1base 7 cm 
above the couch; (3) Four-field plan over Octavius 4D; (4) A 360º arc 
over Octavius 4D. In all cases field size was 10×10 cm2 with 6 MV and 
200 MU per field. Both in pre-treatment mode and during treatment, 
portal images were acquired in integrated mode for each static field 
or cine acquisition for arcs. For pre-treatment mode we used SID 105 
cm and for transit mode 150 cm. Additional measurements were taken 
separately with a Farmer ion chamber mounted in MP1 to check TPS 
calculation. 
Results: Agreement between TPS and ion chamber at isocentre for 
each single field was better than1%. Differences of reference point 
doses between DC and the TPS are shown in table 1. Total dose 
differences are less than 2%, but single field contributions may 
achieve values higher than 5%. 
 Table 1. Differences of reference point doses between DC and the 
TPS. 
 
In transit mode, DC gave unexpected results for fields directly 
affected by the table. Inplan 1, without air gap, the 180º-field 
resulted in equal dose at isocenter than 0°, for the same MU. In plans 
2 and 3, both with air gap, the 180º-field resulted in even more dose 
at isocenter than 0°. 
DC seems not to consider properly the effect of couch attenuation, 
especially when there is an air gap between phantom and couch, 
which could be the case for patients with vacuum mattress. 
Conclusions: The tests carried out with simple plans suggest that the 
accuracy of DC achieves 2% for total dose. However, the study of the 
contribution from each single field shows greater differences. For off-
axis dose distribution and logically for patients this uncertainty will 
result significantly higher. In any case the possibility of this evaluation 
and the potentiality of this new system have a very positive impact on 
improving patient QA. Currently DC system is being used with patients 
and results and uncertainties associated are under evaluation. 
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Purpose/Objective: This study was to evaluate the performance of 2D 
diode array (MapCHECK2,Sun Nuclear) mounted on the Isocentric 
Mounting Fixture (IMF) compared with 3D diode array (ArcCHECK, Sun 
Nuclear) for Volumetric Modulated Arc Therapy(VMAT) plan 
verification. 
Materials and Methods: There were 4 Head-and-Neck (H&N) and 4 
Prostate VMAT plans generated by Eclipse V8.9.17 treatment planning 
system and delivered by Varian Rapid Arc Clinac iX machine. VMAT 
patient plans were measured in actual beam angles by MapCHECK 
diode array with 1527 diode detectors at 5 cm water equivalent 
depth. MapCHECK array was mounted on the isocentric mounting 
fixture (IMF) and attached to the gantry of Rapid Arc machine. The 
same VMAT plans with actual beam angles were measured by 
ArcCHECK with 1386 diode detectors arranged in a spiral pattern with 
10 mm sensor spacing. The agreement between VMAT plan (Eclipse 
calculation) and measurement was evaluated using gamma evaluation 
with 10% dose threshold and 3% absolute dose difference and 3mm 
distance to agreement(DTA). The performance of 2D array and 3D 
array for VMAT plan verification was evaluated by using the 
percentage of passing point between Eclipse plan and measurement.  
Results: For all VMAT plans, the pass rate exceeded 95% using 
MapCHECK 2D array with IMF and 94% using ArcCHECK. The difference 
of % passing point between MapCHECK with IMF and ArcCHECK ranged 
between 0-2 % for each VMAT plan.  
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Conclusions: Performing patient-specific QA for VMAT plan by using 
MapCHECK with IMF tool shows the result of agreement between 
Eclipse plan and measurement comparable with using ArcCHECK 3D 
diode array.  
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Purpose/Objective: The purpose of this work is to determine the 
statistical correlation between 2D IMRT QA passing rates and several 
clinically relevant, anatomy-based dose errors for per patient IMRTQA. 
Materials and Methods: Thirty patients which performed QA of the 
treatment plan of the VMAT(VARIAN MedicalSystems, USA) with 
prostate cancer in the past were examined. Each planned with 10 MV 
linear accelerators (Novalis-Tx; Brain LAB) using a commercial 
treatment planning system (ECLIPSE; VARIAN Medical Systems, USA) 
and VMAT. In this study was compared with 2D or volume gamma pass 
rate and Dose Volume Histogram (DVH), and absolute dose. 2D gamma 
pass rate analysis was measured by 2D pixel ion-chamber (MatriXX; 
IBA, Germany). Volume gamma pass rate and DVH were computed by 
COMPASS MatriXX systems(IBA, Germany). The dose response data 
measured by the MatriXX(IBA, Germany) was imported to the COMPASS 
MatriXX systems, and volume gamma and DVH were calculated. The 
COMPASS MatriXX systems can perform only dose calculation by using 
imported DICOM plan data and dose response. As for the absorbed 
dose was compared with 0.6ml Farmer type ion-chamber and 
COMPASS MatriXX systems. An absorbed dose was compared with mean 
dose of the same area volume as the area volume measured by ion-
chamber of the IMRT phantom, and correlation was investigated. 
Results: A variation of 2D gamma pass rate was larger than volume 
gamma. As a result of performing comparison of 2D gamma pass rate 
and DVH, absorbed dose error was less than 5% in DVH when 2D 
gamma pass rate was more than 95% of PTV. However,even if the 
rectum and bladder were more than 95% gamma pass rate, there was 
dose error more than 5% in 40% of all measured data. There were 
correlated with absolute dose measured by 0.6ml ion-chamber and 
computed by the COMPASS MatriXX systems (p<0.01).  
Conclusions: Although IMRT Plan QA by means of 2D or volume gamma 
pass rate were suitable as objective rating of distribution, it was 
suggested that these were not suitable as clinical assessment of IMRT 
Plan.  
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Purpose/Objective: The introduction of VMAT in clinical routine can 
be limited for the complexity and time needed in pre-treatment 
verification, decreasing the number of patients that could benefit. A 
fast and reliable dosimetric device is then required. Since 2009, over 
400 patients have been treated with Volumetric modulated arc 
therapy (VMAT) at Fondazione di Ricerca e Cura 'Giovanni Paolo II' of 
Campobasso, Italy. In this study we present the three-years results of 
our patient specific QA program using the PTW seven29/Octavius 
system and our institutional guidelines for VMAT delivery.  
Materials and Methods: From June 2009 to October 2012, 410 
patients were treated with VMAT technique at our institution using 
Elekta linacs and Oncentra Masterplan TPS. Patients were divided in 
three groups: (1) 125 patients with high-modulated complex 
treatments for head-neck, rectal, endometrial and brain tumours, all 
treated with Simultaneous Integrated Boost strategy using two arcs; 
(2) 140 patients with prostate and vaginal tumours and (3) 145 
patients undergone to radiosurgery or extracranial stereotactic 
techniques for bone, liver, lung, abdominal and pelvic metastasis, 
treated by one arc. The absolute doses were measured utilizing the 
PTW Seven29 ion-chamber array and the Octavius phantom. VMAT 
plans were recalculated on phantoms representing the Octavius 
geometry and density; for each arc the doses were measured both on 
coronal and sagittal planes, for a total of 1070 measurements. 
Agreement of measured and predicted doses were evaluated using 
gamma index set at 3%/3mm. Three scalar metrics were evaluated for 
each measurement: (a) percentage of points with gamma value less 
than one (Pγ<1), (b) mean gamma (γmean), and (c) maximum gamma 
(γmax). Dose measurements at isocenter point were extracted by the 
seven29 central 0.125 cc ion chamber. 
Results: Pγ<1, γmean and γmax averaged over all treatment sites were 
96.8% ± 3.0%, 0.37 ± 0.08 and 1.58 ± 0.70, respectively. For the 
patients in group (1), Pγ<1, γmean and γmax were 95.7% ± 3.0%, 0.39 ± 
0.08 and 1.90 ± 0.62, respectively. These values reached 98.2% ± 
3.3%, 0.35 ± 0.09 and 1.13 ± 0.61 values in group (2) and 98.3% ± 2.3%, 
0.31 ± 0.08 and 1.24 ± 0.70 values in group (3). Our local confidence 
limits for Pγ<1 were determined to be 9.1% over all treatment sites, 
and 10.2%, 8.1%, and 6.2%, for patients in group 1, 2 and 3, 
respectively. Mean values and SD of ion-chamber differences between 
isocenter measured and calculated doses were -0.4% ± 2.8%, -0.7% ± 
1.6% and 0.5% ± 2.0% for group 1, 2, and 3, respectively, supplying our 
local confidence limit of 5.9%, 3.8% and 4.4%.  
Conclusions: The PTW seven29/Octavius system allows a fast and 
accurate dosimetric procedure for VMAT pre-treatment verification, 
benefiting from all the advantages of ionization chamber absolute 
dosimetry. Despite the increased complexity in VMAT treatments, our 
local confidence limits were comparable to those of AAPM TG 119.  
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Purpose/Objective: In the field of radiotherapy (RT) vast resources 
are being used on quality assurance (QA) to ensure the most precise 
treatment delivery. One important parameter to control and monitor 
is the dosimetric output from the linear accelerator. In recent years 
at this institute, this has been done by weekly output measurements 
with an ion chamber in a Perspex phantom. These measurements have 
been supplemented by daily output measurements using LINACHECK 
from PTW. However, modern linear accelerators allows for such 
measurements using the onboard Electronic Portal Imaging Device 
(EPID). The purpose of this study has been to design, code and 
implement a software solution for measuring and evaluating the daily 
output on the Varian iX and Truebeam accelerators using the EPID. 
Materials and Methods: Daily warm-up and output measurement test 
patients were created for each accelerator. These consisted of four 
fields: two warm-up fields (25 x 25 cm2, 400 MU, 6 and 15 MV) and 
two output measurement fields (25 x 25 cm2, 100 MU, 6 and 15 MV) 
with the EPID positioned at SID = 100 cm and the measurements 
carried out by integrating dose over time. To collect reference data 
and allow for dosimetrically equivalent measurements, the output of 
all accelerators was measured and adjusted in water to within ± 0.3 % 
of reference values. Afterwards the integrated image mode of the 
EPID was calibrated for the clinical used D/R, followed by a dosimetric 
calibration using a 10x10 cm2 field and 100 MU. Reference data was 
then collected using the test patients. All data was exported from the 
TPS as DICOM files. An algorithm for sorting measurements, 
calculating output, beam quality, symmetry and plotting in- and cross-
line profiles was created using MATLAB. For easy accessibility and 
quick handling a graphical user interface (GUI) was also coded using 
the MATLAB GUI editor. Finally the algorithm and GUI were compiled 
to an executable, allowing the software to run independently of a 
MATLAB installation using the MATLAB Compiler Runtime (MCR). 
Several versions of the software was designed, compiled and deployed 
each targeting a specific personal group with different requirements. 
All measurements and results were saved to MATLAB data files for 
storage and easy accessibility. 
Results: A lot of energy was used in the design phase of this project 
which clearly paid out in implementation and evaluation phase, where 
only minor issues related to the software arose, being primarily coding 
errors related to e.g. saving data. As a result of this several new 
versions with error corrections or minor functionality tweaks were 
deployed over the first months of implementation. 
Conclusions: Using MATLAB for creating software to interact with data 
measured using the EPID exported via DICOM has proven itself 
possible, easy and reliable. Making in-house software gives the 
benefits of a highly customizable system alongside complete 
knowledge and control over algorithms and data handling. 
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